AVRAnteris Technologies Global Corp.

Healthcare

$6.63+52% 1Y

$6.63

$3.3852 weeks$10.57

Price

+52%1Y

End-of-day closes, not the intraday tick.

A mixed picture: the questions disagree

Nothing alarming, growth fading, the market undecided.

P/En/a

Market value$645.4M

1 year+52%

5 yearsn/a

Charts

As reported to the SEC, without any scoring.

Anteris Technologies Global Corp. (AVR) reported revenue of $1.0M in Q2 2026 (quarter ended Jun 30, 2026), up 63% from the same quarter a year earlier. That came with a gross margin of 77% and net loss of $29M. For the full year FY2025, revenue was $1.9M (−29% year on year) and net income −$94M. The next results filing is expected around Nov 12, 2026, the same week as a year ago.

What the company said

The company's own words from its current reports to the SEC, newest first

Sep 23, 2026On September 22, 2026, Anteris Aus Operations Pty Ltd (“AAOPL”), a wholly owned subsidiary of Anteris Technologies Global Corp., and Harvey Industries Group Pty Ltd (“Harvey”, together with AAOPL, the “Parties”), entered into an Amendment (the “Amendment”) to that certain Supply & Quality Agreement, executed May 24 …Material agreement entered · Form 8-K
Sep 17, 2026Contingent Grant of Nonqualified Stock Options to Wayne Paterson and David St Denis On September 12, 2026, Anteris Technologies Global Corp. (the “Company”) approved a contingent grant of 1,200,000 nonqualified employee stock options for Wayne Paterson (the “Paterson Option Grant”), and 414,000 nonqualified employee …Director or officer change · Form 8-K
Sep 8, 2026Appointment of Chief Financial Officer On September 4, 2026, Anteris Technologies Global Corp. (the “Company”) appointed Brent Moen as its Chief Financial Officer, effective September 11, 2026.Director or officer change · Form 8-K